The mechanisms of QRQZ on NASH were associated with modulating gut microbiota, thereby inducing the tight junction of gut barrier, reducing the endotoxemia and inhibiting the activation of TLR4/NFkB signaling pathway in liver. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.